Atlas Trials

Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC

Clinical trial NCT03674827 · TERMINATED

Trial details

NCT number
NCT03674827
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Small Cell Lung CancerTriple-negative Breast Cancer
Start date
2018-11-27
Primary completion
2021-09-27
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.